Repligen Corp. Beats Estimates Despite Third Quarter Loss
Bioprocessing firm Repligen Corp. outperformed revenue expectations this quarter despite reporting a $38.4 million net loss.
Live Poll
Does meeting earnings expectations make you more confident in your personal investment plans?